What Is PET/CT?

PET/CT (Positron Emission Tomography combined with Computed Tomography) is a hybrid imaging technique that merges two distinct scanning technologies into a single examination. It combines the functional and metabolic information provided by PET with the detailed anatomical imaging of CT, producing a fused image that shows both what an area of the body looks like and how it is functioning at a cellular level. This combination has made PET/CT one of the most valuable tools in modern diagnostic medicine, particularly in oncology, and is typically interpreted by an Expert Nuclear Medicine Specialist.

How PET/CT Works

The PET Component

PET imaging relies on a small amount of radioactive tracer, most commonly a radiolabeled form of glucose called FDG (fluorodeoxyglucose). Since cancer cells and other metabolically active cells consume glucose at a higher rate than normal tissue, they absorb more of the tracer. The PET scanner detects the radiation emitted by the tracer and creates images that highlight areas of abnormal metabolic activity.

The CT Component

CT imaging uses X-rays to produce detailed cross-sectional images of the body's internal structures, providing precise anatomical detail such as organ size, shape, and location, which a Surgical Oncologist can use for planning treatment.

The Fusion

By overlaying the PET and CT images, physicians can pinpoint the exact anatomical location of areas showing abnormal metabolic activity — something that neither scan could achieve as effectively on its own. This fusion significantly improves diagnostic accuracy and helps guide treatment planning.

Why PET/CT Is Used

PET/CT is used across a wide range of clinical scenarios, including:

• Cancer diagnosis and staging: Detecting the presence, size, and spread of tumors, including distant metastases.

• Treatment monitoring: Assessing how well a cancer is responding to chemotherapy, radiation, or other therapies.

• Detecting recurrence: Identifying whether cancer has returned after treatment, often before it would be visible on other imaging.

• Cardiac evaluation: Assessing blood flow to the heart muscle and identifying viable versus non-viable heart tissue.

• Neurological conditions: Evaluating brain disorders such as epilepsy, dementia, and certain movement disorders.

• Infection and inflammation: Locating sites of infection or inflammatory disease in some cases.

The PET/CT Scan Process

Before the Scan

Patients are typically asked to:

• Avoid eating for several hours (usually 4–6 hours) before the scan, though water is generally permitted

• Avoid strenuous exercise for 24 hours prior, as muscle activity can affect tracer uptake

• Inform their doctor about diabetes, pregnancy, breastfeeding, or claustrophobia

• Wear comfortable clothing without metal fasteners

During the Scan

1. A radioactive tracer is injected into a vein, usually in the arm.

2. The patient rests quietly for about 45–60 minutes to allow the tracer to circulate and be absorbed by tissues.

3. The patient lies still on a table that slides into the PET/CT scanner.

4. The scan itself typically takes 20–45 minutes, during which the patient must remain still to ensure clear images.

After the Scan

Most patients can resume normal activities immediately. Drinking extra fluids helps flush the remaining tracer from the body more quickly. The radioactive tracer loses its activity within a few hours and poses minimal risk to the patient or others.

Benefits of PET/CT

• Detects disease at a metabolic level, often before structural changes appear on other imaging

• Provides both functional and anatomical information in a single exam

• Improves accuracy in cancer staging, which can change treatment decisions

• Helps avoid unnecessary surgeries by identifying whether disease has spread

• Useful for monitoring treatment response in real time

Risks and Considerations

PET/CT is generally considered safe, but there are some considerations:

• Radiation exposure: Both the CT portion and the radioactive tracer expose patients to a small amount of radiation. The benefits typically outweigh the risks for diagnostic purposes, but cumulative exposure is considered for patients requiring repeated scans.

• Allergic reactions: Rare, but possible reactions to the tracer or contrast agents used in some CT scans.

• Pregnancy: PET/CT is generally avoided during pregnancy due to radiation exposure to the fetus, unless medically necessary.

• Blood sugar levels: High blood sugar can interfere with tracer uptake, so diabetic patients may need special preparation instructions.

• False positives/negatives: Inflammation or infection can sometimes cause false-positive results, while very small tumors may occasionally be missed.

PET/CT in Cancer Care

PET/CT plays a central role at several points in the cancer care journey:

• Initial diagnosis: Helping characterize suspicious masses found on other imaging.

• Staging: Determining the extent of disease, including lymph node involvement and distant spread.

• Treatment planning: Assisting radiation oncologists in precisely targeting tumor tissue while sparing healthy tissue.

• Response assessment: Comparing pre- and post-treatment scans to evaluate how well a tumor is responding.

• Surveillance: Monitoring for recurrence after treatment has concluded.

Limitations of PET/CT

While highly valuable, PET/CT is not without limitations. It may not detect very small tumors or certain low-metabolic-activity cancers effectively. It is also not typically used as a first-line screening tool for the general population, but rather as a targeted diagnostic tool once there is clinical suspicion of disease or a need for detailed staging or monitoring.

Conclusion

PET/CT represents a significant advancement in diagnostic imaging by combining metabolic and anatomical information into a single, highly informative scan. Its ability to detect disease activity at a cellular level  often earlier than structural imaging alone  has made it an indispensable tool in oncology, cardiology, and neurology. As with any medical procedure, the decision to undergo a PET/CT scan should be made in consultation with a healthcare provider, weighing the diagnostic benefits against individual risk factors.